[Correction of age related bladder function decrease with peptide geroprotector in women].
Gomberg VG, Ryzhak AP, Lyutov RV · 2013 · Advances in gerontology = Uspekhi gerontologii · PMID 28976156
What does this source report?
The blinded randomized report describes fewer urgency and urge-incontinence symptoms and improved quality of life.
- Population and setting
- Women aged 48–80 with overactive bladder; sample size absent from abstract
- Evidence type
- Randomized trial
- Preparation
- See the original report; formulation details require verification.
- Source language
- English indexed abstract; original language:
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The abstract omits group sizes, numerical treatment effects and allocation details; no reported side effects is not proof of safety.
- Full methods, reporting completeness and independent replication remain to be appraised.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Source provenance: Original journal report
Cite and trace this record
Original source: Gomberg VG, Ryzhak AP, Lyutov RV. [Correction of age related bladder function decrease with peptide geroprotector in women]. Advances in gerontology = Uspekhi gerontologii · PMID 28976156 2013.
Molekul research summary: https://molekul.io/research/audit-28976156. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry